301 related articles for article (PubMed ID: 35490836)
21. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
23. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
24. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
25. δ Opioid Receptor Agonism Preserves the Retinal Pigmented Epithelial Cell Tight Junctions and Ameliorates the Retinopathy in Experimental Diabetes.
Lopes de Faria JM; Duarte DA; Simó R; García-Ramirez M; Dátilo MN; Pasqualetto FC; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3842-3853. PubMed ID: 31529081
[TBL] [Abstract][Full Text] [Related]
26. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
[TBL] [Abstract][Full Text] [Related]
27. VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A
Deissler HL; Stutzer JN; Lang GK; Grisanti S; Lang GE; Ranjbar M
Exp Eye Res; 2020 May; 194():108004. PubMed ID: 32184103
[TBL] [Abstract][Full Text] [Related]
28. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
29. Hypoglycemia Induces Mitochondrial Reactive Oxygen Species Production Through Increased Fatty Acid Oxidation and Promotes Retinal Vascular Permeability in Diabetic Mice.
Yoshinaga A; Kajihara N; Kukidome D; Motoshima H; Matsumura T; Nishikawa T; Araki E
Antioxid Redox Signal; 2021 Jun; 34(16):1245-1259. PubMed ID: 32757614
[No Abstract] [Full Text] [Related]
30. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy.
Qin B; Liu J; Liu S; Li B; Ren J
Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):732-40. PubMed ID: 27421659
[TBL] [Abstract][Full Text] [Related]
31. Triamcinolone Acetonide Suppresses Inflammation and Facilitates Vascular Barrier Function in Human Retinal Microvascular Endothelial Cells.
Imai S; Otsuka T; Naito A; Shimazawa M; Hara H
Curr Neurovasc Res; 2017; 14(3):232-241. PubMed ID: 28625129
[TBL] [Abstract][Full Text] [Related]
32. Blocking Hemopexin With Specific Antibodies: A New Strategy for Treating Diabetic Retinopathy.
Bogdanov P; Duarri A; Sabater D; Salas A; Isla-Magrané H; Ramos H; Huerta J; Valeri M; García-Arumí J; Simó R; Hernández C
Diabetes; 2023 Dec; 72(12):1841-1852. PubMed ID: 37722135
[TBL] [Abstract][Full Text] [Related]
33. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
Leal EC; Martins J; Voabil P; Liberal J; Chiavaroli C; Bauer J; Cunha-Vaz J; Ambrósio AF
Diabetes; 2010 Oct; 59(10):2637-45. PubMed ID: 20627932
[TBL] [Abstract][Full Text] [Related]
34. Silymarin prevents diabetes-induced hyperpermeability in human retinal endothelial cells.
García-Ramírez M; Turch M; Simó-Servat O; Hernández C; Simó R
Endocrinol Diabetes Nutr (Engl Ed); 2018 Apr; 65(4):200-205. PubMed ID: 29422244
[TBL] [Abstract][Full Text] [Related]
35. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.
Rangasamy S; Srinivasan R; Maestas J; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3784-91. PubMed ID: 21310918
[TBL] [Abstract][Full Text] [Related]
36. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats.
Barber AJ; Antonetti DA
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5410-6. PubMed ID: 14638745
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
[TBL] [Abstract][Full Text] [Related]
38. Adenosine Deaminase-2-Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3p.
Samra YA; Saleh HM; Hussein KA; Elsherbiny NM; Ibrahim AS; Elmasry K; Fulzele S; El-Shishtawy MM; Eissa LA; Al-Shabrawey M; Liou GI
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):933-943. PubMed ID: 28170537
[TBL] [Abstract][Full Text] [Related]
39. Effects of an Aquaporin 4 Inhibitor, TGN-020, on Murine Diabetic Retina.
Oosuka S; Kida T; Oku H; Horie T; Morishita S; Fukumoto M; Sato T; Ikeda T
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230876
[TBL] [Abstract][Full Text] [Related]
40. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
